Newsletter | March 10, 2025

03.10.25 -- Accelerating Antibody Delivery With Surf Bio's Bryan Mazlish

FEATURED EDITORIAL

Accelerating Antibody Delivery With Surf Bio's Bryan Mazlish

In this episode of Sit and Deliver, Surf Bio CEO Bryan Mazlish talks with host Tom von Gunden about subcutaneous delivery of monoclonal antibodies (mAbs) and other biologics via autoinjectors. Bryan shares with Tom the benefits of polymer-enabled administration of high-dose antibody treatments outside of infusion centers.

Growth And Advancements In Transdermal Drug Delivery

The transdermal drug delivery system industry is seeing significant growth. Let's look at new market research, including the technologies being used and what therapeutic areas see the most impact.

INDUSTRY INSIGHTS

Gliding Towards De-Risked Combination Product Development

Learn about the critical role plunger stoppers play in determining a combination drug product's exposure to extractables and leachables.

Ensure Speed And Success With Your Drug Delivery Project

Hear from experienced professionals in the drug delivery space on how to ensure success and speed-to-market by establishing a firm foundation when working with a CMO.

Solving Delivery Challenges For Tolerogenic Vaccines

Consider the advantages offered by the freeze-dried Zydis ODT relating to large molecule storage, aggregation, and in some cases, protease activity.

From Scale-Up To Scale-Out To Meet Genetic Medicine Delivery Demand

The shift from "scale-up" to "scale-out" in genetic medicine enhances production speed, revolutionizing pharmaceutical manufacturing and accelerating life-saving therapies for global patient populations.

Development Of Next Gen Sustained Release Solutions For Pain Management

A TheraPEA polymer based injectable formulation designed to deliver the same dose of Triamcinolone Acetonide (TAA) as in Zilretta has shown promising results in a series of pre-clinical studies.

Progressive Testing Of IV Solutions

As IV-administered drugs proliferate, sponsors must understand the associated regulatory requirements, methodologies for useful/required information, and formulations suitable for administration.

SOLUTIONS

Medical Device Risk Management

The Bridge To Delivering Life-Changing Therapies To Patients

Nasal Spray Development And Manufacturing Services